Update on the Phase 4 ENVISION Confirmatory Study of ADUHELM®
Go back to Update on the Phase 4 ENVISION Confirmatory Study of ADUHELM®| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 210.73 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $210.73 | 52 Week High | $333.65 | |||
| Open | $210.73 | 52 Week Low | $223.02 | |||
| Day High | $210.73 | P/E | 26.98 | |||
| Day Low | $210.73 | EPS | $7.81 | |||
| Volume | 37 | |||||

